Medpace Holdings Inc
MEDP: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| V>> | LOCK|q??&N | LOCK|#Xw@fr& |
Medpace Earnings: Elevated Cancellations and Weak Gross Bookings Raise Concerns; Shares Tank 23%
Medpace reported 26% year-over-year revenue growth to $706 million in the first quarter, but its backlog declined $98 million sequentially to $2.93 billion amid elevated cancellations and weak bookings, driving a net book/bill ratio of only 0.88 versus 1.04 in the fourth quarter.
